Febuxostat AB 120 mg film-coat. tabl.

Pajjiż: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Febuxostat 120 mg

Disponibbli minn:

Aurobindo SA-NV

Kodiċi ATC:

M04AA03

INN (Isem Internazzjonali):

Febuxostat

Dożaġġ:

120 mg

Għamla farmaċewtika:

Film-coated tablet

Kompożizzjoni:

Febuxostat 120 mg

Rotta amministrattiva:

Oral use

Żona terapewtika:

Febuxostat

Sommarju tal-prodott:

CTI code: 538257-07 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-08 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-05 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-06 - Pack size: 84 - Commercialisation status: YES - FMD code: 08716049031999 - CNK code: 3911120 - Delivery mode: Medical prescription; CTI code: 538257-09 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-10 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-11 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-14 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-04 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-12 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538257-13 - Pack size: 84 - Commercialisation status: YES - FMD code: 08716049031999 - CNK code: 3911120 - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

2019-01-22